Biotech New Lows: Akebia Therapeutics (NASDAQ:AKBA), Galmed Pharmaceuticals (NASDAQ:GLMD), Tetralogic Pharmaceuticals (NASDAQ:TLOG), Dipexium Pharmaceuticals (NASDAQ:DPRX)

Akebia Therapeutics Inc. (NASDAQ:AKBA) offered 5.9 million shares in its Thursday IPO at $17 a share, the high end of the stock’s expected price range. Among other therapeutics, the biopharma company is developing a once-daily oral therapy for patients with kidney disease. Akebia Therapeutics, Inc. (NASDAQ:AKBA) stock performance was -0.99% in last session and finished the day at $20.00. Traded volume was 219,904 million shares … Continue reading Biotech New Lows: Akebia Therapeutics (NASDAQ:AKBA), Galmed Pharmaceuticals (NASDAQ:GLMD), Tetralogic Pharmaceuticals (NASDAQ:TLOG), Dipexium Pharmaceuticals (NASDAQ:DPRX)

Kevin Long03/2603/26

Why Need to Watch: Dipexium Pharmaceuticals(NASDAQ:DPRX), Yahoo! Inc. (NASDAQ:YHOO), UMH Properties (NYSE:UMH), Consolidated Edison, Inc. (NYSE:ED), The Medicines Company (NASDAQ:MDCO)

On 13 AUG Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) released its earnings data on Wednesday. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.37) by $0.09. Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) belongs to Healthcare sector. Its weekly performance is -2.28%. On last trading day company shares ended up $9.00. Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) distance from 50-day simple moving average (SMA50) is -5.49%. … Continue reading Why Need to Watch: Dipexium Pharmaceuticals(NASDAQ:DPRX), Yahoo! Inc. (NASDAQ:YHOO), UMH Properties (NYSE:UMH), Consolidated Edison, Inc. (NYSE:ED), The Medicines Company (NASDAQ:MDCO)

Jayne Crisman08/2608/27